The penny stock of Galena Biopharma Inc (Nasdaq: GALE) is having another positve trading session after Wall Street analysts at Cantor Fitzgerald set a “buy” rating and a $4.00 price target on the stock yesterday. GALE shares are currently up 2.96% at $1.39 on volume of 1,458,273. ...
5
JUN
JUN
0
Share
